Literature DB >> 6261570

Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril.

R K Ferguson, P H Vlasses.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6261570     DOI: 10.1016/0002-8703(81)90233-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  9 in total

Review 1.  Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension.

Authors:  M G Myers; S G Carruthers; F H Leenen; R B Haynes
Journal:  CMAJ       Date:  1989-05-15       Impact factor: 8.262

2.  Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects.

Authors:  P U Witte; R Irmisch; P Hajdú; H Metzger
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  Vasodilators in acute circulatory failure.

Authors:  C Blakeley; J Tinker
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

4.  Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.

Authors:  S Ricci; P Zaniol; V Teglio; P Baraldi; G Mattioli
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

5.  "Scalded mouth" caused by angiotensin-converting-enzyme inhibitors.

Authors:  P H Vlasses; H H Rotmensch; R K Ferguson; S L Sheaffer
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-05

Review 6.  Inhibitors of the angiotensin I converting enzyme as antihypertensive drugs.

Authors:  P A Van Zwieten; A De Jonge; P B Timmermans
Journal:  Pharm Weekbl Sci       Date:  1983-10-21

7.  Effects of captopril on pulmonary haemodynamics.

Authors:  C Richard; J L Ricome; A Rimailho; M Conrad; P Auzépy
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 8.  Clinical pharmacology: special safety considerations in drug development and pharmacovigilance.

Authors:  Kwame N Atuah; Dyfrig Hughes; Munir Pirmohamed
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

9.  Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.

Authors:  U Dahlström; B E Karlberg
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.